Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform
Authors:
- Valentina Palacio-CastañedaVPValentina Palacio-Castañeda
- Rik Oude EgberinkRERik Oude Egberink
- Arbaaz SaitASArbaaz Sait
- Lea AndréeLALea Andrée
- Benedetta Maria SalaBSBenedetta Maria Sala
- Negar Hassani BesheliNBNegar Hassani Besheli
- Egbert OosterwijkEOEgbert Oosterwijk
- Johan NilvebrantJohan Nilvebrant
- Sander C. G. LeeuwenburghSander C. G. Leeuwenburgh
- Roland BrockRBRoland Brock
- Wouter P. R. VerdurmenWouter P. R. Verdurmen
Open Access
- 17 November 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (11) , 1944
Abstract
To investigate the delivery of next-generation macromolecular drugs, such as engineered proteins and mRNA-containing nanoparticles, there is an increasing push towards the use of physiologically relevant disease models that incorporate human cells and do not face ethical dilemmas associated with animal use. Here, we illustrate the versatility and ease of use of a microfluidic platform for studying drug delivery using high-resolution microscopy in 3D. Using this microfluidic platform, we successfully demonstrate the specific targeting of carbonic anhydrase IX (CAIX) on cells overexpressing the protein in a tumor-mimicking chip system using affibodies, with CAIX-negative cells and non-binding affibodies as controls. Furthermore, we demonstrate this system’s feasibility for testing mRNA-containing biomaterials designed to regenerate bone defects. To this end, peptide- and lipid-based mRNA formulations were successfully mixed with colloidal gelatin in microfluidic devices, while translational activity was studied by the expression of a green fluorescent protein. This microfluidic platform enables the testing of mRNA delivery from colloidal biomaterials of relatively high densities, which represents a first important step towards a bone-on-a-chip platform. Collectively, by illustrating the ease of adaptation of our microfluidic platform towards use in distinct applications, we show that our microfluidic chip represents a powerful and flexible way to investigate drug delivery in 3D disease-mimicking culture systems that recapitulate key parameters associated with in vivo drug application.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (17615)
- Radboud Universitair Medisch Centrum (n/a)
This publication has 36 references indexed in Scilit:
- Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chipJournal of Controlled Release, 2014
- A novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environmentLab on a Chip, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Animal Models in an Age of Personalized MedicinePersonalized Medicine, 2011
- Oppositely Charged Gelatin Nanospheres as Building Blocks for Injectable and Biodegradable GelsAdvanced Materials, 2011
- Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and TherapyEuropean Urology, 2010
- Biology of HIF-1αCell Death & Differentiation, 2008
- Translation of Research Evidence From Animals to HumansJAMA, 2006
- Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical ExperienceJournal of Clinical Oncology, 2006
- Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domainNature Biotechnology, 1997